Dr. Kurt Wallersteiner and Hans Enoch, whose development of a new anti-infection drug known as vivicillin has been hailed by British medical and governmental circles, are Jewish refugees from Germany, it was learned there today.
Dr. Wallersteiner told the Jewish Telegraphic Agency that both he and Dr. Enoch had been disappointed that in all the reports of their work on vivicillin no mention has made of the fact that they are Jewish refugees. The drug, which is similar to penicillin, has been found effective in treating different types of serious war casualties as well as civilian ailments. It can be produced quickly and inexpensively.
Dr. Wallersteiner arrived in England in 1936 and is still “stateless” although the is technical manager of the Watford Chemical Co. He comes from an old Jewish family which settled in Octtingen-Wallerstein in the 16th century. His grandfather was head of the Jewish community there, and his father was a well known doctor. He is a Zionist and plans to go to Palestine to make scientific investigations, he disclosed.
Dr. Enoch came from Hamburg, where he worked in a serum company founded by his father, who was a prominent scientist. He has engaged in much important war work here and is technical manager of the international Serum Company.
JTA has documented Jewish history in real-time for over a century. Keep our journalism strong by joining us in supporting independent, award-winning reporting.
The Archive of the Jewish Telegraphic Agency includes articles published from 1923 to 2008. Archive stories reflect the journalistic standards and practices of the time they were published.
